Legend Biotech USA Annual Revenue, Competitors, Number of Employees and Funding

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Biotech
Founded:2014
Lead Investor(s):N/A
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Legend Biotech USA's estimated annual revenue is currently $29.1M per year.
  • Legend Biotech USA's estimated revenue per employee is $155,000

Employee Data

  • Legend Biotech USA has 188 Employees.
  • Legend Biotech USA grew their employee count by 132% last year.
  • Legend Biotech USA currently has 22 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Hydromer
$8.8M57N/AN/A
SCYNEXIS
N/A43N/AN/A
Cellectar Biosc...
N/A19N/AN/A
Soligenix
N/A27N/AN/A
Gibraltar Labor...
$9M58N/AN/A
Apprentice.io
$4.5M29N/AN/A
AES CHEMUNEX
$3.4M22N/AN/A
GENEWIZ
$87.6M5653%N/A
Celsion Corpora...
N/A38N/AN/A
Hitachi Chemica...
$40.1M25913%N/A
Missing a competitor? Contribute!?
Submit

Legend Biotech Corporation is an emerging company focusing on the development of the best-in-class immunotherapy technology for cancer cure. Teamed up with outstanding immunologists and molecular biologists, Legend has generated a strong pipeline of Chimeric Antigen Receptor(CAR) product candidates to treat a wide variety of liquid and solid tumors. Our ambition to succeed in the CARs field has been substantially fulfilled by the latest clinical trial results that we have achieved a great clinical success in treating multiple myeloma, a previously incurable blood cancer. By applying one of our proprietary CAR-T technology, we have reached a promising result in the clinical research for the enrolled patient group bearing refractory and relapsed multiple myeloma. Legend Biotech Corporation is founded on the vision that the previous incurable previousincurable cancer will be safely and effectively treated with fine-tuning products generated on our innovative technology platform. We take our mission very seriously and intend to bring more hopes to desperate patients all over the world.

keywords:N/A

188

Number of Employees

$29.1M

Revenue (est)

22

Current Jobs

132%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Jerry ZhouAssociate Director of FinanceEmail Available
Rong ZhouDirector, Regulatory Affairs Cmc, Biologics/car-tEmail Available
Yuan XuCEOEmail Available
Grisel PierrezDirector of External QualityEmail Available
Raghu TadagavadiAssociate DirectorEmail Available
Steve GavelVice President, Cell Therapy Commercial Development LeadEmail Available
Bryan UtterDirector of Material SciencesEmail Available
Liz GosenSVP, Technical OperationsEmail Available
Minal PatelQuality Control ManagerEmail Available
Mike HirschmannExecutive Director Commecial Development

Legend Biotech USA News

17-Aug-19 - CAR T Cell Therapy Market 2019 To Touch Impressive Growth ...

... Sorrento Therapeutics (US), Legend Biotech (US), Mustang Bio (US), ... The US is expected to hold the largest share of the global CAR T cell ...

07-Sep-19 - A PhII flop triggers an ugly rout for micro-cap biotech Aridis ...

Micro-cap biotech Aridis Pharmaceuticals $ARDS got hammered this ... drug status by US and EU regulators for its experimental drug, elafibranor, ... pit Immunotech against Legend Biotech, a J&J-partnered player owned by ...

7-Mar-19 - Legend Biotech officially opens its European HQ in Dublin

In 2017, Janssen entered into a global collaboration and licence agreement with Legend Biotech USA and Legend Biotech Ireland to develop, ...